Investigating the role of TDP43 protein in brain function and neurodegenerative diseases

Synaptic TDP43 in the Adult Mouse Brain

NIH-funded research Columbia University Health Sciences · NIH-11075555

This study is looking at how a protein called TDP43, which builds up in the brains of people with Alzheimer's and ALS, affects thinking and memory, hoping to find new ways to help treat these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11075555 on NIH RePORTER

What this research studies

This research focuses on understanding how the TDP43 protein, which accumulates abnormally in various neurological disorders, affects cognitive function in conditions like Alzheimer's Disease and Amyotrophic Lateral Sclerosis. By using advanced techniques to analyze TDP43 interactions in the brains of mouse models, the study aims to uncover the molecular mechanisms that contribute to cognitive impairment. The findings could lead to new insights into how these diseases progress and potentially identify targets for therapeutic intervention.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's Disease, Frontotemporal Dementia, or Amyotrophic Lateral Sclerosis.

Not a fit: Patients with neurodegenerative diseases not related to TDP43 dysfunction may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients suffering from neurodegenerative diseases.

How similar studies have performed: Previous research has shown promising results in understanding TDP43's role in neurodegeneration, indicating that this approach may yield valuable insights.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.